Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
Mattia Trunfio, Elena Salvador, Daniela Cabodi, Letizia Marinaro, Chiara Alcantarini, Alberto Gaviraghi, Alice Trentalange, Filippo Lipani, Savino Sciascia, Dario Roccatello, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)HeparinLow molecular weight heparinCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakVirologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesThermal Regulation in MedicineHeart Rate Variability and Autonomic Control